![Caroline Fichtner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Fichtner
Director/Board Member at
Thermosome GmbH
Profile
Caroline Fichtner is currently the Director at Thermosome GmbH and the Principal & Authorized Signatory at High-Tech Gründerfonds Management GmbH.
Previously, she worked as an Analyst at PolyTechnos Venture-Partners GmbH.
Dr. Fichtner holds a graduate degree from Ruhr-Universität Bochum, an undergraduate degree from the University of Münster, and a doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Caroline Fichtner active positions
| Companies | Position | Start |
|---|---|---|
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Private Equity Investor | 01/03/2006 |
Thermosome GmbH
 Thermosome GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs for solid tumors | Director/Board Member | - |
Former positions of Caroline Fichtner
| Companies | Position | End |
|---|---|---|
PolyTechnos Venture-Partners GmbH
 PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields. | Private Equity Analyst | 31/05/2002 |
Training of Caroline Fichtner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ruhr-Universität Bochum
 Ruhr-Universität Bochum Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Finance |
PolyTechnos Venture-Partners GmbH
PolyTechnos Venture-Partners GmbH Investment ManagersFinance PTVP originally focused on early-stage investing in advanced technology sectors, then evolved towards later-stage investments. Their portfolio companies are typically European high-growth companies where they identified a special situation likely to create significant value within a short period of time, a unique business model, limited technology risk, limited burn rate, and an identified value inflection point for a global trade sale or an IPO. PTVP's focus is on German-speaking countries. They provide hands-on support to promote the global development of their investee companies. Their portfolio is invested in sectors including software, information technology, life sciences, energy and clean technology, as well as in companies born of the convergence of these fields. | Finance |
Thermosome GmbH
Thermosome GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs for solid tumors | Health Technology |
- Stock Market
- Insiders
- Caroline Fichtner
